← FDA Drug Approvals (Drugs@FDA)

EVEROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2026-02-25

Drug application

FDA Application #

ANDA219533

Application type

Abbreviated New Drug Application (Generic)

Brand name

EVEROLIMUS

Generic name

EVEROLIMUS

Active ingredients

EVEROLIMUS

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EUGIA PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2026-02-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown